An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.
Experimental Treatment Gaining Traction Online
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Viewers are encouraged to contact these profiles directly for supplier links, while also obtaining discount codes.
Thriving Commerce on Social Networks
Separately, a flourishing trade exists on Telegram, where communities with numerous of members share “before and after” images, injection guides and claims of next-day UK delivery. Vendors market the substance there before redirecting customers to other platforms for purchases.
Understanding Retatrutide
This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Medical Professionals Express Worries
However, physicians and pharmacists have cautions that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could lead to individuals injecting substances of unknown origin.
Some professionals stated the demand for retatrutide could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.
Legal Status and Implementation
Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Some influencers try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still violate medicines, marketing, and customer laws, potentially leading to fines, legal action or imprisonment.
Service Response and Material Removal
Based on TikTok, the service has taken down problematic content and banned associated hashtags and search suggestions. The organization stated it was committed to maintaining the service safe and allocating resources in enhancing enforcement strategies.
Digital Marketplace Operations
Research also found communities with up to 9,000 participants selling retatrutide using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly displays channels with thousands of members, filled with images of weight loss, positive testimonials and step-by-step instructions for preparing or injecting at home.
After moments of joining one community, a vendor shared WhatsApp details, where most purchases occur. The seller provided an instruction manual and guaranteed shipping within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about body mass, health issues or previous experience.
Product Information and Pricing
Inside these communities, posts show black plastic parcels with postal service labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with sterile water, or pre-filled injectors usually sold at £160 for 20 milligrams. When asked how long a injector should last, vendors give conflicting answers varying between a several days to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for the messaging service stated it regularly monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are administering materials they cannot confirm. Although the research behind this drug is sound, these online products may not include what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of an online medical service linked the surge in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, individuals are using social media. But fake treatments are extremely risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.
Her team has previously encountered individuals injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”
Producer Position
A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly investigational product not yet approved … may expose users to potentially serious health risks”.
